AS
ORMP icon

Altshuler Shaham’s Oramed Pharmaceuticals ORMP Stock Holding History

Altshuler Shaham’s Portfolio ORMP Stock Details ORMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$38.1K Hold
11,211
– – ﹤0.01% 193
2025
Q4 		$32K Hold
11,211
– – ﹤0.01% 185
2025
Q3 		$29.6K Sell
11,211
-643
-5% -$1.42K ﹤0.01% 165
2025
Q2 		$26.6K Hold
11,854
– – ﹤0.01% 169
2025
Q1 		$25.4K Hold
11,854
– – ﹤0.01% 155
2024
Q4 		$28.6K Sell
11,854
-166
-1% -$394 ﹤0.01% 160
2024
Q3 		$29.4K Hold
12,020
– – ﹤0.01% 108
2024
Q2 		$30.9K Hold
12,020
– – ﹤0.01% 114
2024
Q1 		$35.1K Sell
12,020
-827
-6% -$2.31K ﹤0.01% 113
2023
Q4 		$29.6K Hold
12,847
– – ﹤0.01% 146
2023
Q3 		$33.4K Hold
12,847
– – ﹤0.01% 163
2023
Q2 		$46.1K Hold
12,847
– – ﹤0.01% 171
2023
Q1 		$28K Hold
12,847
– – ﹤0.01% 294
2022
Q4 		$153K Buy
+12,847
New +$99.9K 0.01% 106

Other funds holding ORMP

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
AF
Aquamarine Financial George Town $1.37B AUM
Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $67.6B AUM 18.3% 1-Year Est. Return
GIA
Gem Investment Advisors Teaneck, New Jersey $102M AUM
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Altshuler Shaham's ORMP Position: Q1 2026 in Review

Altshuler Shaham held its Oramed Pharmaceuticals (ORMP) position steady in Q1 2026 at 11,211 shares worth $38.1K. The position accounts for ﹤0.01% of the portfolio, ranked #193.

Altshuler Shaham first reported a position in ORMP in Q4 2022 and has held it in 14 quarters since. The position peaked at $153K in Q4 2022. 64 funds tracked by Wall St. Rank hold ORMP as of Q1 2026.

  • Altshuler Shaham held 11,211 shares of Oramed Pharmaceuticals worth $38.1K as of Q1 2026.
  • Altshuler Shaham left its Oramed Pharmaceuticals share count unchanged in Q1 2026.
  • Oramed Pharmaceuticals made up ﹤0.01% of Altshuler Shaham's portfolio in Q1 2026, its #193 holding.
  • Altshuler Shaham first reported a position in Oramed Pharmaceuticals in Q4 2022 and has held it in 14 quarters since.
  • Altshuler Shaham's Oramed Pharmaceuticals position peaked at $153K in Q4 2022.
  • 64 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q1 2026.

Based on Altshuler Shaham's 13F filing for Q1 2026, filed 18 May 2026.